[go: up one dir, main page]

NO911786L - MUTEINS OF GRANULOZYTE COLONY-STIMULATING FACTORS. - Google Patents

MUTEINS OF GRANULOZYTE COLONY-STIMULATING FACTORS.

Info

Publication number
NO911786L
NO911786L NO91911786A NO911786A NO911786L NO 911786 L NO911786 L NO 911786L NO 91911786 A NO91911786 A NO 91911786A NO 911786 A NO911786 A NO 911786A NO 911786 L NO911786 L NO 911786L
Authority
NO
Norway
Prior art keywords
granulozyte
muteins
colony
stimulating factors
stimulating
Prior art date
Application number
NO91911786A
Other languages
Norwegian (no)
Other versions
NO911786D0 (en
Inventor
Guenter Schumacher
Carola Dony
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO911786D0 publication Critical patent/NO911786D0/en
Publication of NO911786L publication Critical patent/NO911786L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K26/00—Working by laser beam, e.g. welding, cutting or boring
    • B23K26/351—Working by laser beam, e.g. welding, cutting or boring for trimming or tuning of electrical components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plasma & Fusion (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91911786A 1990-05-08 1991-05-07 MUTEINS OF GRANULOZYTE COLONY-STIMULATING FACTORS. NO911786L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014750A DE4014750A1 (en) 1990-05-08 1990-05-08 MUTEINE OF THE GRANULOCYTE-STIMULATING FACTOR (G-CSF)

Publications (2)

Publication Number Publication Date
NO911786D0 NO911786D0 (en) 1991-05-07
NO911786L true NO911786L (en) 1991-11-11

Family

ID=6405959

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911786A NO911786L (en) 1990-05-08 1991-05-07 MUTEINS OF GRANULOZYTE COLONY-STIMULATING FACTORS.

Country Status (17)

Country Link
EP (1) EP0456200A1 (en)
JP (1) JPH04225998A (en)
KR (1) KR940000757B1 (en)
CN (1) CN1057862A (en)
AU (1) AU631312B2 (en)
CA (1) CA2041439A1 (en)
CS (1) CS133391A3 (en)
DE (1) DE4014750A1 (en)
FI (1) FI912203L (en)
HU (1) HUT58801A (en)
IE (1) IE911359A1 (en)
IL (1) IL98070A0 (en)
NO (1) NO911786L (en)
NZ (1) NZ237975A (en)
PL (1) PL290166A1 (en)
PT (1) PT97611A (en)
ZA (1) ZA913430B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8058398B2 (en) 1993-01-28 2011-11-15 Amgen Inc. Modified G-CSF polypeptide

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718893A (en) * 1984-04-15 1998-02-17 Foster; Preston F. Use of G-CSF to reduce acute rejection
GB9107846D0 (en) * 1990-04-30 1991-05-29 Ici Plc Polypeptides
US5536495A (en) * 1994-04-15 1996-07-16 Foster; Preston F. Use of G-CSF to reduce acute rejection
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
KR100440460B1 (en) * 1998-07-08 2004-10-08 주식회사유한양행 Gene, recombinant vector and transformant of hG-CSF and method of producing hG-CSF using the same
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
DE19860801A1 (en) * 1998-12-30 2000-07-06 Rhein Biotech Proz & Prod Gmbh Recombinant growth factor with the biological activity of a G-CSF (Granulocyte Colony Stimulating Factor)
US6946548B2 (en) * 2000-09-08 2005-09-20 Massachusetts Institute Of Technology G-CSF analog compositions and methods
JP4279554B2 (en) 2001-02-19 2009-06-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Method for identifying T cell epitopes and method for producing molecules having reduced immunogenicity
KR100961859B1 (en) 2001-07-11 2010-06-09 맥시겐 홀딩스 엘티디 G-CS conjugate
US20040247562A1 (en) * 2001-09-28 2004-12-09 Sang Yup Lee Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
US7785601B2 (en) 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US7695723B2 (en) 2002-12-31 2010-04-13 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US7220407B2 (en) 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
DE102004041639A1 (en) 2004-08-27 2006-03-02 Bioceuticals Arzneimittel Ag Method for obtaining biologically active human G-CSF from inclusion bodies
WO2006055260A2 (en) 2004-11-05 2006-05-26 Northwestern University Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders
BRPI0611221A2 (en) 2005-06-01 2010-08-24 Maxygen Holdings Ltd pegylated g-csf polypeptides and their production methods
DE102005033250A1 (en) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Process for purifying G-CSF
DE102006009437A1 (en) 2006-03-01 2007-09-13 Bioceuticals Arzneimittel Ag G-CSF liquid formulation
EP2578677A1 (en) 2007-08-09 2013-04-10 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
ES2476915T3 (en) 2007-08-27 2014-07-15 Ratiopharm Gmbh Liquid G-CSF conjugate formulation
CA2697376C (en) 2007-08-27 2016-07-19 Walter Hinderer Liquid formulation of g-csf
DE202007018629U1 (en) 2007-08-27 2008-12-24 Biogenerix Ag Liquid formulation of G-CSF
WO2009046015A2 (en) 2007-09-30 2009-04-09 University Of Florida Research Foundation, Inc. Combination therapies for treating type 1 diabetes
MX2012010148A (en) 2010-03-04 2013-01-22 Pfenex Inc Method for producing soluble recombinant interferon protein without denaturing.
PL2552949T3 (en) 2010-04-01 2017-01-31 Pfenex Inc. Methods for g-csf production in a pseudomonas host cell
EP2399572A1 (en) 2010-06-22 2011-12-28 Sandoz AG Long-term storage of non-glycosylated recombinant human G-CSF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06102021B2 (en) * 1985-12-03 1994-12-14 中外製薬株式会社 Novel polypeptide
JPS63500636A (en) * 1985-08-23 1988-03-10 麒麟麦酒株式会社 DNA encoding multipotent granulocyte colony stimulating factor
EP0256843A1 (en) * 1986-08-11 1988-02-24 Cetus Corporation Expression of g-csf and muteins thereof and their use
HU215241B (en) * 1986-10-24 1998-11-30 Cetus Corp. A method for preparing new forms of colony stimulating factor-1 and for producing expression cassette, vector and recombinant host cells useful in the method.
NO176799C (en) * 1986-12-23 1995-05-31 Kyowa Hakko Kogyo Kk DNA encoding a polypeptide, recombinant plasmid that encodes and can express a polypeptide and method for producing this polypeptide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8058398B2 (en) 1993-01-28 2011-11-15 Amgen Inc. Modified G-CSF polypeptide

Also Published As

Publication number Publication date
PT97611A (en) 1992-03-31
KR940000757B1 (en) 1994-01-29
ZA913430B (en) 1992-02-26
IL98070A0 (en) 1992-06-21
DE4014750A1 (en) 1991-11-14
NZ237975A (en) 1992-09-25
KR910020033A (en) 1991-12-19
CS133391A3 (en) 1992-01-15
JPH04225998A (en) 1992-08-14
CA2041439A1 (en) 1991-11-09
CN1057862A (en) 1992-01-15
HUT58801A (en) 1992-03-30
FI912203A0 (en) 1991-05-07
FI912203A7 (en) 1991-11-09
NO911786D0 (en) 1991-05-07
AU631312B2 (en) 1992-11-19
AU7638091A (en) 1991-11-14
EP0456200A1 (en) 1991-11-13
PL290166A1 (en) 1992-01-13
IE911359A1 (en) 1991-11-20
HU911529D0 (en) 1991-11-28
FI912203L (en) 1991-11-09

Similar Documents

Publication Publication Date Title
NO911786L (en) MUTEINS OF GRANULOZYTE COLONY-STIMULATING FACTORS.
FI931357A0 (en) FRAMSTAELLNING AV POLYHYDROXIFETTSYRAAMIDER I NAERVARO AV LOESNINGSMEDEL
FI932024L (en) FOERFARANDE FOER AOSTADKOMMANDE AV KONTROLERADE UTSKILJNINGSPROFILER I KIESELSKIVOR
FI911738A7 (en) ANORDNING FOER ADMINISTERING AV PULVERFORMIGA MEDICINSKA AEMNEN.
FI914727A0 (en) SYSTEM FOER TORKNING AV FAERSK TRAE.
FI930509L (en) ANVAENDNING AV GRAENSYTPOLIMERISERADE MEMBRANER I DOSERINGSANORDNINGAR
FI911704L (en) FOERBEHANDLING AV FYLLMEDEL MED KATJONISK KETENDIMER.
FI924512L (en) FOERFARANDE FOER SYNKRONISERING AV EN PSEUDOSLUMPMAESSIG BINAERSEKVENS I EN DESSCRAMBLER
ITMI912655A1 (en) COMBINATION OF EXTRUDER-CALENDER.
FI923779L (en) FOERBAETTRINGAR I TILLVERKNINGEN AV NYLONGARN
TR25073A (en) PREPARATION OF POLYCETONE POLYMERS.
FI870297L (en) FOERFARANDE FOER SKYDDANDE AV TRAE.
FI910931A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV PLATTOR AV MASSIVT TRAE.
FI900286A0 (en) FOERFARANDE OCH ANORDNING FOER FLISHUGGNING AV TRAE.
FI923812L (en) ANORDNING FOER AOSTADKOMMANDE AV EN RYMDLADDNING I ATMOSFAEREN
FI931669L (en) FOERFARANDE FOER FRAMSTAELLNING AV I FORM GJUTNA SKODON AV OLIKA BREDD
FI910466A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV FORMADE FOEREMAOL MED UTMAERKT SLAGHAOLLFASTHET.
FI915518L (en) FOERFARANDE FOER FRAMSTAELLNING AV HETEROCYKLISKT SUBSTITUERADE PIPERAZINOOALKYLBENSOXAZIN- OCH -TIATZIN FOERENINGAR MED LAEKEMEDELSVERKAN.
FI913285A0 (en) MEVINSYRADERIVAT OF SVAVELSUBSTITUERADE.
NO901462L (en) SKOTING OF CONSTRUCTION ELEMENTS.
FI913044A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV EN SUPRALEDANDE MULTIFILAMENTTRAOD AV EN MED KOPPAR STABILISERAD NB-TI -LEGERING.
FI930123L (en) FOERFARANDE FOER ANVAENDNING AV OXIDERADE LIPOPROTEINER I VIRUSARTADE INFEKTIONER
FI906046A7 (en) SPINNHJULSENHET FOER FIBRERING AV MINERALSMAELTA MED HJAELP AV CENTRIFUGALKRAFTEN.
FI901078A0 (en) BRANDSKYDD MED FOERKOLNING AV TRAE.
FI902512A0 (en) FOERFARANDE FOER IMPREGNERING AV FUKTIGT TRAE.